Summary
Colgate-Palmolive Company (CL) filed an 8-K on April 30, 2015, primarily to announce its financial results for the quarter ended March 31, 2015, via an attached press release. While the specific financial details are within the press release (Exhibit 99), the 8-K itself serves as the formal notification of this earnings release to investors and the market. Additionally, the filing disclosed the upcoming retirement of Vice Chairman Andrew D. Hendry, effective July 1, 2015. Mr. Hendry, who had previously served as Chief Legal Officer and Secretary, will be retiring after 24 years with the company. The company expressed gratitude for his long and distinguished service.
Key Highlights
- 1Colgate-Palmolive announced its Q1 2015 earnings on April 30, 2015.
- 2The Q1 2015 earnings press release is attached as Exhibit 99 to the 8-K.
- 3The company is providing an update on its financial condition and results of operations for the quarter ended March 31, 2015.
- 4Vice Chairman Andrew D. Hendry will retire on July 1, 2015.
- 5Mr. Hendry has served the company for 24 years.
- 6Mr. Hendry previously held the role of Chief Legal Officer and Secretary.
Frequently Asked Questions
The main purpose of this 8-K filing is to formally announce Colgate-Palmolive's earnings for the first quarter of 2015 and to include the accompanying press release as an exhibit. It also serves to inform the public about the retirement of a key executive.
The detailed financial results for the quarter ended March 31, 2015, are available in the press release attached as Exhibit 99 to this 8-K filing. Investors should refer to that press release for specific revenue, profit, and other financial metrics.
Andrew D. Hendry is the Vice Chairman of Colgate-Palmolive. He has had a long career of 24 years with the company and previously served as its Chief Legal Officer and Secretary. His retirement is effective July 1, 2015.
This 8-K filing primarily serves as notification of the earnings release and executive retirement. Specific financial details, projections, or forward-looking guidance would typically be found within the content of the attached earnings press release (Exhibit 99), rather than in the body of the 8-K form itself.